This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,458,000.00 to The University of Texas MD Anderson Cancer Center to conduct research on "The Role of Androgens in Regulating Extracellular Vesicle Secretion and Molecular Cargo Loading by Prostate Cancer Cells." The 3-year project, beginning on March 1, 2024, aims to investigate how androgens, male sex hormones, influence the production and molecular content of extracellular vesicles released by prostate cancer cells. This research has the potential to advance the understanding of prostate cancer biology and identify new targets for therapeutic interventions. As a comprehensive cancer research and treatment center, MD Anderson has extensive experience conducting federal grant-funded projects spanning basic, translational, and clinical cancer research.
Generated 10/29/24, 5:38 AM